The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...

One of the biggest names in adult entertainment, Emily Willis, has been left permanently disabled after checking into a Malibu rehab center for drug addiction treatment, ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

A team of US-based scientists have found "a probable causal connection" between a form of bacteria found in the human gut and the onset of depression.Carried out by a team from Harvard University and ...

Mind Medicine (MindMed) has dosed the first subject in the Phase III Panorama study of a proprietary form of lysergide ...

Following the Supreme Court’s overturning Roe v. Wade, conversations about male hormonal birth control have never been more ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...

A green alga that grows in lakes and rivers could be the next "superfood"—helping scientists to tackle global food security challenges while promoting environmental sustainability, a new study reveals ...

ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 360,300 ...

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...